DK1838392T3 - Selenholdige medikamenter mod endotheliale vaskulære sygdomme - Google Patents

Selenholdige medikamenter mod endotheliale vaskulære sygdomme

Info

Publication number
DK1838392T3
DK1838392T3 DK06700374.9T DK06700374T DK1838392T3 DK 1838392 T3 DK1838392 T3 DK 1838392T3 DK 06700374 T DK06700374 T DK 06700374T DK 1838392 T3 DK1838392 T3 DK 1838392T3
Authority
DK
Denmark
Prior art keywords
selenium
vascular disease
containing drugs
endothelial vascular
endothelial
Prior art date
Application number
DK06700374.9T
Other languages
English (en)
Inventor
Thomas Stiefel
Original Assignee
Biosyn Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyn Arzneimittel Gmbh filed Critical Biosyn Arzneimittel Gmbh
Application granted granted Critical
Publication of DK1838392T3 publication Critical patent/DK1838392T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06700374.9T 2004-12-31 2006-01-02 Selenholdige medikamenter mod endotheliale vaskulære sygdomme DK1838392T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063638A DE102004063638A1 (de) 2004-12-31 2004-12-31 Selen-haltige Medikamente zur Prophylaxe oder Therapie von endothelialen Gefäßerkrankungen
PCT/EP2006/000007 WO2006070022A2 (de) 2004-12-31 2006-01-02 Selen-haltige medikamente gegen endotheliale gefasserkrankungen

Publications (1)

Publication Number Publication Date
DK1838392T3 true DK1838392T3 (da) 2011-06-27

Family

ID=36129753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06700374.9T DK1838392T3 (da) 2004-12-31 2006-01-02 Selenholdige medikamenter mod endotheliale vaskulære sygdomme

Country Status (8)

Country Link
EP (1) EP1838392B1 (da)
AT (1) ATE503527T1 (da)
DE (2) DE102004063638A1 (da)
DK (1) DK1838392T3 (da)
ES (1) ES2360886T3 (da)
PL (1) PL1838392T3 (da)
PT (1) PT1838392E (da)
WO (1) WO2006070022A2 (da)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1112164A (en) * 1977-08-02 1981-11-10 Joseph R. Levitt Therapeutic selenium compositions and the use thereof
DE4335441A1 (de) * 1993-10-18 1995-04-20 Hans Dipl Chem Heide Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen
AU1938895A (en) * 1994-05-02 1995-11-29 Abbott Laboratories Inhibition of atherosclerosis by antioxidants
US5929063A (en) * 1995-03-24 1999-07-27 Children's Hospital Medical Center Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
DK1317272T3 (da) * 2000-05-25 2006-08-14 Boehringer Ingelheim Int Middel til forbedret cellebeskyttelse omfattende en lipofil antioxidant og en hydrofil antioxidant
WO2002067853A2 (en) * 2000-10-06 2002-09-06 Probiochem, Llc A combination and method of treatment of hiv and viral diseases, vascular disease and cancer utilizing a cox-2 inhibitor and cystine
US20020182585A1 (en) * 2001-01-10 2002-12-05 George Kindness Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
DE10321029A1 (de) * 2003-05-10 2004-12-02 Sigrid Heide Arzneimittel mit Selenit
CA2530634A1 (en) * 2003-06-12 2004-12-23 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium and selenium compounds
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
ITRM20040395A1 (it) * 2004-08-03 2004-11-03 Sigma Tau Ind Farmaceuti Composizione comprendente statine e acidi grassi omega 3.
DE102004040006A1 (de) * 2004-08-18 2006-03-09 Kurt Mosetter Pharmazeutische Zusammensetzung, umfassend Galaktose, Selen, Vitamin E und/oder Phosphatidylcholin und pharmazeutische Verwendung von Galaktose

Also Published As

Publication number Publication date
ATE503527T1 (de) 2011-04-15
DE502006009204D1 (de) 2011-05-12
PT1838392E (pt) 2011-04-29
EP1838392B1 (de) 2011-03-30
WO2006070022A2 (de) 2006-07-06
DE102004063638A1 (de) 2006-07-13
ES2360886T3 (es) 2011-06-10
EP1838392A2 (de) 2007-10-03
PL1838392T3 (pl) 2011-09-30
WO2006070022A3 (de) 2007-04-19

Similar Documents

Publication Publication Date Title
NO20084531L (no) Bruk av flibanserin for behandling av post-menopause seksuell lyst lidelser
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
NO20081527L (no) Anvendelse av flibanserin for behandling av pre-menopausal seksuell lyst forstyrrelser
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
NO20065227L (no) Menoklonale antistoff mot hepatocytt vekstfaktor
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
UA94580C2 (ru) Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
RU2008127882A (ru) Лечение пищевода барретта
ATE543804T1 (de) Neue verbindungen
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
EA200801425A1 (ru) Диазепиноны
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
PT1778837E (pt) Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4
ECSP077843A (es) Tratamiento o prevención del prurito
EA201171229A1 (ru) Терапевтическое применение производных хиназолиндиона при сердечно-сосудистых заболеваниях
EA200601514A1 (ru) Производные пиперазинмочевины для лечения эндометриоза
DK1838392T3 (da) Selenholdige medikamenter mod endotheliale vaskulære sygdomme
EA201000739A1 (ru) Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата
EA200100876A3 (ru) Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12
ATE339206T1 (de) Verwendung von lornoxicam oder lornoxicam-analoga verbindungen